You are on page 1of 1

U8854

High Impact Polystyrene

Product Information
• Excellent melt flow.
• Good mechanical resistance.
• Gloss and translucency.
• Suitable for injection and blow-injection and processes that need fast cycles and economic.
(1)
• Approved for food contact

ASTM
Inglês Internacional
Properties Method Unit Value Unit Value

Melt Flow Rate(2) D-1238 g/10min 8.5 g/10min 8.5

Tensile Modulus D-638 psi 290.000 Mpa 2.000

Tensile Modulus at yield D-638 psi 2.900 Mpa 20

Elongation at break D-638 % >40 % >40


(3)
IZOD
Impact Strength @ 23 oC D-256/A Lbfxft/in 1.7 J/m 90
(4)
VICAT Softening Temperature
o o
(B/50) D-1525 C 88 C 88
Heat Deflection Temperature
(load)(5)(A) @ 264psi / 1,82 MPa D-648 o
C 80 o
C 80

Density D-792 g/cm 3 1,06 g/cm 3 1,06

Water Absorption D-570 % 0,03 % 0,07

Classified according to UL - 94HB


1. “Resolution 51 and 52 of the National Health Surveillance Agency (105/99 - Brazil/Mercosur)” and FDA USA 21 CFR 177.1640.
o
2. Test under condition: 200 C / 5 kg.
3. Test specimen molded by injection of 63/12,6/3,5 mm ( C/L/E ); Notch cutting radius 0,25R +/- 0,05; Depth 2,54 mm.
o
4. Test performed with weight of 5kg and heating 50 C /h.
5. Test specimen molded by injection of 128/13/6,3 mm ( C/L/E ). Test Load of 264 psi.

OBSERVATIONS
1- The descriptions, data and information contained in this specifications sheet are merely informational and are offered in good faith, as they are
meant for the most technically suitable application of the product. The data provided are typical figures for the guidance of our customers, and
they should not be construed as specification limits, as many factors may influence the parameters of the properties. Accordingly, we assume no
liability for complying to them either correctly or incorrectly. Furthermore, we refrain from ensuring their ineffability, or that their application would
infringe any industrial privilege. For further information or additional clarification, our technical department is entirely at your disposal.
2- This product complies with Resolution 105/99 of the National Health Surveillance Agency - ANVISA (Brazil/Mercosur).

January/2015

You might also like